Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FKKD1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,603
Award facts
- Contract value 100% obligated
- $24,602.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) issued a delivery order valued at $24,602.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, awarded on November 20, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation, reflecting the vendor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply solutions to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical system, with a single-award IDC valued at $499.9 million and extending through December 31, 2036. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with EXPAREL—a specialty surgical anesthetic product—representing one of its specialized offerings. As the sole awardee on this delivery order with no identified subcontractors, DMS Pharmaceutical Group leverages its established performance across multiple product categories to fulfill the diverse pharmaceutical requirements of Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FKKD1?
SPE2DR26FKKD1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FKKD1 worth?
The government has obligated $24,603 on SPE2DR26FKKD1.
Is contract SPE2DR26FKKD1 an order under another contract?
Yes. SPE2DR26FKKD1 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKD1 competed?
The extent of competition for SPE2DR26FKKD1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award